Watch for Cabenuva, a New Monthly Injectable for HIV

Cabenuva (cabotegravir/rilpivirine) will be the first MONTHLY antiretroviral treatment for adults living with HIV.

It’s given as two IM gluteal injections at the same visit. Each Cabenuva kit has one vial of cabotegravir, an integrase inhibitor...and one vial of rilpivirine, a non-nucleoside reverse transcriptase inhibitor.

Viral load suppression with Cabenuva seems similar to standard 3-med oral DAILY regimens, such as Biktarvy or Triumeq.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote